Skip to content
LATEST
Markets

SenesTech CEO lifts stake to 9,000 shares with $840 purchase

The micro-cap pest management firm lifted third-quarter revenue 59% year on year to $1.1 million, though persistent cash burn kept operations unprofitable.

SenesTech CEO lifts stake to 9,000 shares with $840 purchase

SenesTech Inc. Chief Executive Officer Michael Edell bought 1,000 common shares for $840 on Sept. 14, according to a Form 4 filed with the U.S. Securities and Exchange Commission.

The purchase at $0.84 per share increases Edell's direct holding to 9,000 shares as the rodent fertility control developer attempts to commercialize its platform, following third-quarter revenue of $1.1 million that rose 59% from a year earlier.

Sequential revenue climbed 42% to exceed expectations, driven by distribution agreements on Amazon, company web sales, and business-to-business commercial accounts. SenesTech generated record gross profit of $796,000, achieving a 72.6% gross margin, while recurring subscription revenue surged 53% quarter on quarter and 234% year on year.

Despite product revenue momentum, the company remains unprofitable over the trailing twelve months and continues to burn cash. SenesTech shares fell 2.06% to close at $0.862 on the Nasdaq, extending recent weekly declines as equity investors weigh operational growth against continued capital burn.

Source: Securities filing, Securities and Exchange Commission, Nov. 16, 2026.

More stories

Latest news